Notwithstanding the decision of the World Health Organisation (WHO) to suspend clinical trials of Hydroxychloroquine and Chloroquine for the treatment of COVID-19, the National Agency for Food and Drug Administration and Control (NAFDAC) will continue the experiment in Nigeria, the agency's Director-General, Prof. Mojisola Adeyeye, has said.
She said yesterday on a Lagos-based private broadcast station, TVC, programme, that there were proven records that Hydroxychloroquine had been effective in the treatment of COVID-19 patients, especially those at the "mild stage" of the virus.
WHO on Monday announced the temporary suspension of the clinical trials of Hydroxychloroquine as a potential drug for the treatment of COVID-19.
Jonathan Urges Africa to Look Inward for Remedies
Former President Goodluck Jonathan has urged African countries to look inward for home-grown solutions.
US Company Begins Clinical Trial of Vaccine
An American biotechnology company, Novavax, has commenced human trials of COVID-19 vaccine in Australia.
